Search research articles
Contact Us
Filters
Showing results (51-60 of 131) with videos related to
Page
of 14
Sort By:
Cancer
|
June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases
Lance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Cancers
|
August 28, 2025
Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
Yusra Medik, Sehrish Sardar, Jaskirat S Sethi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2014
Isolated renal mucormycosis in a transplantation recipient
Amir Hamdi, Victor E Mulanovich, Surena F Matin, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 14, 2019
Primary Malignant Thyroid Teratoma: An Institutional Experience
Jose Ting, Diana Bell, Salmaan Ahmed, et al.
Cancers
|
February 10, 2024
Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics
Shi-Ming Tu, Jim Z Chen, Sunny R Singh, et al.
The American Journal of Surgical Pathology
|
August 2, 2021
Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases
Michael J Hwang, Ameer Hamza, Miao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma
Lance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Urologic Oncology
|
September 9, 2010
Recurrent seminomas: clinical features and biologic implications
Avik Som, Rui Zhu, Charles C Guo, et al.
Cancer Chemotherapy and Pharmacology
|
February 4, 2011
Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib
Paul Mathew, Nizar Tannir, Shi-Ming Tu, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
June 3, 2021
Diagnostic performance of <sup>18</sup>F-fluciclovine PET/CT in prostate cancer patients with rising PSA level ≤ 0.5 ng/ml after multiple treatment failures
Ajalaya Teyateeti, Achiraya Teyateeti, Gregory C Ravizzini, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 131) with videos related to
Sort By:
Page
of 14
Cancer
|
June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases
Lance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Cancers
|
August 28, 2025
Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
Yusra Medik, Sehrish Sardar, Jaskirat S Sethi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2014
Isolated renal mucormycosis in a transplantation recipient
Amir Hamdi, Victor E Mulanovich, Surena F Matin, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 14, 2019
Primary Malignant Thyroid Teratoma: An Institutional Experience
Jose Ting, Diana Bell, Salmaan Ahmed, et al.
Cancers
|
February 10, 2024
Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics
Shi-Ming Tu, Jim Z Chen, Sunny R Singh, et al.
The American Journal of Surgical Pathology
|
August 2, 2021
Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases
Michael J Hwang, Ameer Hamza, Miao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma
Lance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Urologic Oncology
|
September 9, 2010
Recurrent seminomas: clinical features and biologic implications
Avik Som, Rui Zhu, Charles C Guo, et al.
Cancer Chemotherapy and Pharmacology
|
February 4, 2011
Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib
Paul Mathew, Nizar Tannir, Shi-Ming Tu, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
June 3, 2021
Diagnostic performance of <sup>18</sup>F-fluciclovine PET/CT in prostate cancer patients with rising PSA level ≤ 0.5 ng/ml after multiple treatment failures
Ajalaya Teyateeti, Achiraya Teyateeti, Gregory C Ravizzini, et al.
Page
of 14